Resources

Within3 is Committed to Providing the Most Relevant Information in the Industry

Medical Affairs Case Study Eastern Europe, Non-English, Sleep Disorders

August 16, 2017 | Case Study

A leading pharmaceutical organization’s medical affairs team purposed with acquiring expert feedback across Ukraine. Further, the team needed an alternative meeting option that would prove both cost-effective and logistically friendly. This case study examines how they took an innovative approach to achieving the necessary engagement outcomes.

Read More

Full Clinical Ecosystem Engagement

August 10, 2017 | Case Study

Learn how a leading pharmaceutical organization's commercial team took an innovative approach to achieving necessary physician and clinical engagement outcomes.

Read More

Acquiring Expert Clinical Insights

July 20, 2017 | Case Study

Acquiring expert clinical insights and perspectives is critical throughout the lifecycle of a drug. The findings often serve to have cross-organizational impact – shaping both medical affairs and commercial team decision-making and related efforts. A leading pharmaceutical organization’s medical affairs team was purposed with acquiring multi-touchpoint feedback about these types of patient-centric topics on the subject of lymphatic blood-based cancer. This case study examines how they took an innovative approach to achieving the necessary engagement outcomes.

Read More

Improving Clinical Decision-Making Outcomes

June 15, 2017 | Case Study

Purposeful discussions between pharmaceutical organizations and healthcare professionals (HCPs) are critical throughout the lifecycle of a compound. Discover how a clinical development team within a leading pharmaceutical organization, that was purposed with acquiring feedback on a biological agent which would serve as a therapeutic target, took an innovative approach to gaining increased KOL participation and feedback, while reducing costs by nearly 60%. The feedback would entail HCP perspectives on single ascending dose and multiple dose study design, opinions on trial timing, design, population, and other key study elements.

Read More

Improving Steering Committee Outcomes

May 11, 2017 | Case Study

Pharmaceutical organizations are routinely wrestling with questions ranging from clinical insights, to market penetration and expansion, to access and coverage. Because steering committees bring together internal and external experts to provide periodic (and often unscheduled) feedback to the committee chairs throughout the year, they are highly effective in working through these issues. However, scheduling and logistical challenges can make steering committees hard to execute efficiently - particularly when factoring in time zone differences, travel, and scheduling coordination, and the need for quick and timely feedback. A leading pharmaceutical organization, facing these challenges, took an innovative approach to engaging their committee members. This case study examines how they did it.

Read More